Taiwan FDA registration d8d4e54132df38a4888638bd3157b8db
"Navellister" Fixi implantable infusion seat system
TW: "娜維利斯特"斐克希植入式輸液座系統
Taiwan·Risk Class 2·NAVILYST MEDICAL, INC.·Registered Dec 01, 2006 – Dec 01, 2021CancelledRegistration details
- Analysis ID
- d8d4e54132df38a4888638bd3157b8db
- Customs Code
- DHA00601746302
Company information
- Manufacturer
- NAVILYST MEDICAL, INC.
- Manufacturer Country
- United States
- Authorized Representative
- LORION ENTERPRISES INC.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- J General hospital and personal use equipment
- Product Type (Level 2)
- J.5965 Subcutaneous implantable intravascular injection port and guide
- Import Information
- import
Dates and status
- Registration Date
- Dec 01, 2006
- Expiry Date
- Dec 01, 2021
- Cancellation Date
- Oct 12, 2023
Cancellation information
- Status
- Logged out
- Reason
- 未展延而逾期者
About this record
Access comprehensive regulatory information for "Navellister" Fixi implantable infusion seat system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d8d4e54132df38a4888638bd3157b8db and manufactured by NAVILYST MEDICAL, INC.. The authorized representative in Taiwan is LORION ENTERPRISES INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices